Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro.

Human umbilical cord blood (UCB) hematopoietic stem cells (HSC) receive increased attention as a possible target for gene-transfer in gene therapy trials. Diseases affecting the lymphoid lineage, as adenosine deaminase (ADA) deficiency and acquired immunodeficiency syndrome (AIDS) could be cured by gene therapy. However, the T-cell progenitor potential of these HSC after gene-transfer is largely unknown and was up to now not testable in vitro. We show here that highly purified CD34++ Lineage marker-negative (CD34++Lin-) UCB cells generate T, natural killer (NK), and dendritic cells in a severe combined immunodeficient mouse fetal thymus organ culture (FTOC). CD34++Lin- and CD34++CD38-Lin- UCB cells express the retroviral encoded marker gene Green Fluorescent Protein (GFP) after in vitro transduction with MFG-GFP retroviral supernatant. Transduced cells were still capable of generating T, NK, and dendritic cells in the FTOC, all expressing high levels of GFP under control of the Moloney murine leukemia virus (MoMuLV) long terminal repeat promotor. We thus present an in vitro assay for thymic T-cell development out of transduced UCB HSC, using GFP as a marker gene.

[1]  B. Vandekerckhove,et al.  Phenotypic and functional maturation of TCR gammadelta cells in the human thymus. , 1997, Journal of immunology.

[2]  B. Vandekerckhove,et al.  Phenotypic and functional maturation of TCR γδ cells in the human thymus , 1997 .

[3]  B. Blom,et al.  Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage. , 1997, Journal of immunology.

[4]  H. Matsuzaki,et al.  Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro. , 1997, Blood.

[5]  M. Cella,et al.  Identification of a Committed T Cell Precursor Population in Adult Human Peripheral Blood , 1997, The Journal of experimental medicine.

[6]  B. Vandekerckhove,et al.  Phenotypic and functional maturation of TCR ?d cells in the human thymus , 1997 .

[7]  B. Verhasselt,et al.  Interleukin-7 is a critical growth factor in early human T-cell development. , 1996, Blood.

[8]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[9]  E. Gluckman.  Umbilical cord blood transplant in human. , 1996, Bone marrow transplantation.

[10]  I. Plavec,et al.  Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells. , 1996, Gene therapy.

[11]  G. Dranoff,et al.  A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. , 1996, Blood.

[12]  K. Mansfield,et al.  In vitro T lymphopoiesis of human and rhesus CD34+ progenitor cells. , 1996, Blood.

[13]  D. Kohn,et al.  Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Thomas O. Toole,et al.  Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. , 1996, Blood.

[15]  C. Eaves,et al.  Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. , 1996, Blood.

[16]  Li Wu,et al.  Early T lymphocyte progenitors. , 1996, Annual review of immunology.

[17]  J. Wagner,et al.  Unrelated donor bone marrow transplantation for hematological malignancies-current status. , 1996, Leukemia & lymphoma.

[18]  S Falkow,et al.  FACS-optimized mutants of the green fluorescent protein (GFP). , 1996, Gene.

[19]  S. Kalams,et al.  Generation of human T lymphocytes from bone marrow CD34+ cells in vitro , 1996, Nature Medicine.

[20]  H. Heslop,et al.  Measuring gene–transfer efficiency , 1996, Nature Medicine.

[21]  D. Luton,et al.  Aorta-associated CD34+ hematopoietic cells in the early human embryo. , 1996, Blood.

[22]  G. Crooks,et al.  A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. , 1995, Blood.

[23]  B. Verhasselt,et al.  Differentiation to T helper cells in the thymus. Gradual acquisition of T helper cell function by CD3+CD4+ cells. , 1995, Journal of immunology.

[24]  R Y Tsien,et al.  Understanding, improving and using green fluorescent proteins. , 1995, Trends in biochemical sciences.

[25]  A. Galy,et al.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.

[26]  K. Weinberg,et al.  Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency , 1995, Nature Medicine.

[27]  F. Staal,et al.  Development of retrovirally marked human T progenitor cells into mature thymocytes. , 1995, International immunology.

[28]  A. Bahnson,et al.  Centrifugal enhancement of retroviral mediated gene transfer. , 1995, Journal of virological methods.

[29]  R. Mulligan,et al.  Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Nienhuis,et al.  Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. , 1995, Blood.

[31]  B. Vandekerckhove,et al.  Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. , 1994, Blood.

[32]  H. Malech,et al.  CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease , 1994 .

[33]  J. Li,et al.  Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene. , 1994, Gene therapy.

[34]  J. Zack,et al.  Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. , 1994, Blood.

[35]  D. Williams,et al.  Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease , 1993, The Journal of experimental medicine.

[36]  P. Lansdorp,et al.  Expression of Thy-1 on human hematopoietic progenitor cells , 1993, The Journal of experimental medicine.

[37]  Ihor R. Lemischka,et al.  Developmental potential and dynamic behavior of hematopoietic stem cells , 1986, Cell.

[38]  J. Unkeless.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.

[39]  E. M. Smogorzewska,et al.  A Functional Comparison of CD 34 + CD 38-Cells in Cord Blood and Bone Marrow , 2022 .